Using deep viral sequencing we identified low-frequency mutations in experimentally validated CD8 T cell epitopes of SARS-CoV-2, some of which were found as fixed mutations in global virus sequences from @GISAID. 2/7
Guided by binding predictions we selected epitopes and #mutants for further biochemical investigations by cell-free MHC-I binding assays. These analyses suggested that single amino acid changes impair binding to MHC-I molecules. 3/7
PBMC experiments from #COVID-19 patients highlighted a strongly impaired CD8 T cell response towards mutant viral peptides. 4/7
This was confirmed and extended by #scRNA-seq and TCR clonotype analysis. 5/7
Such epitope mutations may impact T cell responses with current #vaccines that only include the viral S gene. This is yet another reason for close monitoring of emerging viral mutations and to develop vaccines inducing broad immune responses. 6/7
#Epidemiological and #Phylogenetic data revealed the geographic origins and distributions of SARS-CoV-2 in Austria. Different viruses circulated in the ski-resort region of #Ischgl with the most dominant #Tyrol-1 linked to @nextstrain clade 20C. 3/8
With #Epidemiological and #Phylogenetic data we investigated the geographic origins and distributions of SARS-CoV-2 in Austria. Different viruses circulated in the ski-resort region of #Ischgl with the most dominant #Tyrol-1 linked to @nextstrain clade 20C.